Guy Pratt is Professor of Haematology (Haemato-Oncology) at the University of Birmingham and Deputy Director of the Cancer Research UK Clinical Trials Unit with responsibility for Haematology trials. He is secretary for the British Society for Haematology, on the exec committee for the UK Myeloma Society and trustee for the charity Cure Leukaemia. He is an Honorary Consultant Haematologist at University Hospitals Birmingham NHS Foundation Trust. He has been a Consultant Haematologist in Birmingham since 2001 with a clinical and research interest in Multiple Myeloma, Waldenstroms Macroglobulinaemia, plasma cell disorders such as amyloidosis and CLL. He trained at Cambridge University qualifying in 1989. Following junior doctor training in London he specialized as a specialist registrar in Haematology in Liverpool and Leeds. In Leeds he completed an MD thesis in Multiple Myeloma. He was clinical lead for the 2016 NICE myeloma guidelines and had a number of previous positions nationally including BSH guideline lead for Haemato-Oncology, trustee for BSH, trustee for the charity WMUK, and chair of the BSH science and publication committee. Over the years he has developed a large number of research collaborations with over 180 peer reviewed publications and including clinical trial involvement both locally and nationally on several trials as a co-investigator and is member of UK Myeloma trials group (UKMRA).